SPC198
Baricítíníb
Status:
AfturkölluðApplication date:
7.7.2017Application published:
15.8.2017
Medicine name:
OlumiantMedicine for children:
No
Timeline
Today
7.7.2017Application
15.8.2017Publication
Marketing license
IS authorization number:
EU/1/16/1170/009-016; EU/1/16/1170/001-008Date:
21.2.2017
Foreign authorization number:
EU/1/16/1170Date:
13.2.2017
Owner
Name:
Incyte Holdings CorporationAddress:
1801 Augustine Cut-Off, Wilmington US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2288610